Ghana vs Least developed countries: Antiretroviral therapy coverage for PMTCT
Ghana
99.0%
in 2024
Least developed countries
85.2%
in 2024
Ghana rank
5th
Least developed countries rank
6th
Antiretroviral therapy coverage for PMTCT over time
- Ghana
- Least developed countries
How they compare
Ghana currently reports 99.0% against 85.2% in Least developed countries, a difference of 13.8%.
That makes Ghana's figure about 1.2 times Least developed countries's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Least developed countries ahead.
Ghana ranks 5th and Least developed countries ranks 6th of 84 countries.
Across the 3 decades both report, Ghana averaged higher in 1 and Least developed countries in 2.
Head to head by decade
| Decade | Ghana | Least developed countries | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.6% | 16.9% | 7.3% | Least developed countries |
| 2010s | 59.9% | 69.9% | 10.0% | Least developed countries |
| 2020s | 89.0% | 83.8% | 5.2% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Ghana or Least developed countries?
- Ghana, at 99.0% against 85.2% in Least developed countries as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Ghana and Least developed countries?
- 13.8%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Least developed countries?
- 25 years are reported by both, from 2000 to 2024.
- How do Ghana and Least developed countries rank globally for antiretroviral therapy coverage for pmtct?
- Ghana ranks 5th and Least developed countries ranks 6th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).